Pharmaceutical Technology on MSN
Solve Therapeutics raises $120m as MSD joins list of backers
In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of ...
LLC) in the Philippines, a subsidiary of the global biopharmaceutical company Merck & Co., Inc., officially launched “Gen V: Your Vibe, Your Move,” a youth-driven movement designed to boost education ...
Pharmaceutical Technology on MSN
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming ...
The LDL-C reductions seen with enlicitide in both studies are in the same ballpark as those seen with injectable ...
MSD has announced positive results from its phase 3 CORALreef Lipids trial, showing that enlicitide decanoate, an investigational oral PCSK9 inhibitor, significantly reduced low-density lipoprotein ...
Pharmaceutical Technology on MSN
MSD secures $700m for broad-cancer ADC asset
ADCs remain à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to advance its pipeline in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback